Physician profile
Brant Ridder
NPI 1295469336
$4,191.25
in general payments reported to CMS, 2019-2025
22 companies · $2,048 in 2025
The $2,048 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.30 · 2024: $2,128 · 2025: $2,048.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,688 · Education: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,688.33 |
| Education | $502.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $831.62 | 2024-2025 | |
| Genzyme Corporation | $500.68 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $412.31 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $383.95 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $320.80 | 2024-2025 | Sotyktu |
| Lilly USA, LLC | $311.12 | 2024-2025 | Taltz, Olumiant, Ebglyss |
| Janssen Biotech, INC. | $304.59 | 2024-2025 | Tremfya |
| Incyte Corporation | $191.12 | 2024-2025 | Opzelura |
| Sanofi-Aventis U.S. LLC | $151.99 | 2024-2025 | |
| Amgen INC. | $133.81 | 2024 | Otezla |
| Ucb, INC. | $133.28 | 2024-2025 | Bimzelx |
| Organon LLC | $115.77 | 2024-2025 | Vtama |
| Regeneron Healthcare Solutions, INC. | $108.58 | 2024-2025 | Dupixent |
| Mayne Pharma Commercial LLC | $72.90 | 2024 | |
| Galderma Laboratories, L.P. | $53.17 | 2025 | Nemluvio |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $43.20 | 2025 | Adbry |
| Pfizer INC. | $37.53 | 2024 | |
| Convatec INC. | $20.73 | 2025 | |
| Dermavant Sciences, INC. | $17.91 | 2024 | Vtama |
| Cipher Pharmaceuticals US LLC | $16.00 | 2025 | Spinosad, Natroba |
| Dexcom, INC. | $15.30 | 2023 | Dexcom G6 Transmitter |
| Lnhc, INC | $14.89 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brant Ridder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.